Bulletin
Investor Alert

Topics

Centers for Disease Control and Prevention

Video

As Kids' Covid-19 Vaccine Nears, Doctors Work to Ease Parent Concerns

  • As Kids' Covid-19 Vaccine Nears, Doctors Work to Ease Parent Concerns As Kids' Covid-19 Vaccine Nears, Doctors Work to Ease Parent Concerns 5:53
    Fully Vaccinated People Don't Need Masks in Most Settings, CDC Says Fully Vaccinated People Don't Need Masks in Most Settings, CDC Says 1:43
    WSJ Opinion: Teachers Unions, Public Schools and That 'Covid' Relief Bill WSJ Opinion: Teachers Unions, Public Schools and That 'Covid' Relief Bill 4:14
    Moderna Delivers Covid-19 Shots, Boosts Vaccination Campaign Moderna Delivers Covid-19 Shots, Boosts Vaccination Campaign 1:52
3:29 a.m. Nov. 19, 2021 - By Tomi Kilgore
Moderna COVID-19 vaccine booster gets FDA OK for all adultsShare of Moderna Inc. shot up 6.0% in premarket trading Friday, after the biotechnology company said the U.S. Food and Drug Administration has extended the emergency use authorization (EUA) of a booster dose of its COVID-19 vaccine to all adults, aged 18 and older. The booster dose is for those who have completed COVID-19 vaccinations, with any authorized or approved vaccine, at least six months ago. "This emergency use authorization comes at a critical time as we enter the winter months and face increasing COVID-19 case counts and hospitalizations across the country," said Moderna Chief Executive Stéphane Bancel. Next, an advisory committee of the U.S. Centers for Disease Control and Prevention (CDC) will meet to discuss a potential recommendation for rolling out COVID-19 boosters. Moderna's stock has tumbled 33.1% over the past three months through Thursday but has soared 140.7% year to date, while the S&P 500 has gained 25.3% this year.
1:47 a.m. Nov. 17, 2021 - By Ciara Linnane
Coronavirus tally: Global cases of COVID-19 above 254.5 million and FDA may authorize boosters for all adults by ThursdayThe global tally for the coronavirus-borne illness climbed above 254.5 million on Wednesday, while the death toll edged above 5.11 million, according to . The U.S. continues to lead the world with a total of 47.3 million cases and 765,913 deaths. The U.S. is still averaging more than 1,100 deaths a day, although cases and hospitalizations are declining, outside of hot spots that include Illinois, Minnesota, Colorado and New Mexico. The Food and Drug Administration is aiming to authorize booster doses of the vaccine developed by Pfizer and German partner BioNTech for all adults above the age of 18 as early as Thursday, citing people familiar with the agency's plans. The Centers for Disease Control and Prevention's advisory panel is due to meet Friday to discuss data on the safety and efficacy of boosters. If both public agencies agree, the program could be expanded as soon as this weekend. India is second by cases after the U.S. at 34.5 million and has suffered 464,153 deaths. Brazil has second highest death toll at 611,478 and 21.9 million cases. In Europe, Russia has the most fatalities at 254,292 deaths, followed by the U.K. at 143,598.
11:24 a.m. Nov. 3, 2021 - By Robert Schroeder
'Get your children vaccinated,' Biden urges after shots for kids 5-11 approved President Joe Biden on Wednesday urged parents of young children to get them vaccinated, a day after the Centers for Disease Control and Prevention to the COVID-19 vaccine developed by Pfizer and BioNTech . The decision marked the first opportunity for U.S. children under 12 to get the protection of any COVID-19 vaccine. Speaking at the White House, Biden said vaccines would be available at 20,000 locations across the country, including schools and community health centers. "You can now protect them from this horrible virus," Biden said of young children. The president also addressed a stunning loss by the Democratic candidate in Virginia's gubernatorial election and said voters want the party to "get things done."
1:24 a.m. Nov. 1, 2021 - By Ciara Linnane
Moderna says FDA needs more time to review COVID vaccine in 12-to-17-year oldsModerna Inc. said it would delay filing a request with the U.S. Food and Drug Administration to emergency use authorization of its COVID-19 vaccine at the 50 µg dose level in children ages 6 to 11, to give the regulator time to complete its review of an earlier submission for use in adolescents 12 to 17 years of age. The company announced the news in a Sunday release, in which it said the FDA had informed it that it needed more time to complete its assessment of the request for the 100 µg dose level in 12-to-17-year-olds. The agency told Moderna late Friday that it would need more time to review the data on the risk of myocarditis after vaccination. It said the review may not be completed before January of 2022. "An increased risk of myocarditis has been described for COVID-19 vaccines, including the Moderna COVID-19 vaccine, particularly in young men and following the second dose," the company said. It noted that both the U.S. Centers for Disease Control and Prevention and the World Health Organization have said that myocarditis following vaccination with mRNA vaccines has been "rare and generally mild." About 1.5 million adolescents have received the Moderna vaccine and the rare condition has been showed to be an increased risk in that age group, said the release. Moderna shares were down 2.2% premarket but have gained 240% in the year to date, while the SPDR S&P Biotech ETF has fallen 11% and the S&P 500 has gained 22.6%.
1:44 a.m. Oct. 29, 2021 - By Ciara Linnane
CDC adds mental health conditions to list of disorders that make a person eligible for COVID vaccine boosterThe Centers for Disease Control and Prevention has added mental health conditions to the list of maladies that make a person more likely to get severely ill with COVID-19. The move makes millions more Americans eligible for booster shots of a COVID-19 vaccine. The agency said the change was made on Oct. 14 and adds patients with depression, schizophrenia and other disorders to the list, which already includes people over the age of 65, those with weakened immune systems or those that are at high risk of contracting the virus through their daily work. About one in five American adults experience some form of mental health issue every year, according to the
1:28 a.m. Oct. 27, 2021 - By Ciara Linnane
Coronavirus tally: Global cases of COVID-19 top 244.6 million and FDA advisors back Pfizer's COVID-19 shot for childrenThe global tally for the coronavirus-borne illness climbed above 244.6 million on Wednesday, while the death toll edged above 4.96 million, according to . The U.S. continues to lead the world with a total of 45.6 million cases and 738,883 deaths. The U.S. is averaging more than 1,400 deaths a day, although cases and hospitalizations are declining. A group of scientists who advise the Food and Drug Administration said the benefits of the Pfizer/BioNTech vaccine outweigh the risks for children between the ages of 5 and 11. The 17-0 vote in favor of the vaccine puts the U.S. one step closer to the first authorization of a shot for this age group. One member abstained. The next step is the FDA's decision. The regulator is not required to follow the recommendation of the committee, but it often does. The final regulatory stamp of approval has to come from the Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices, which is set to meet next Tuesday and Wednesday, and the CDC director herself. India is second by cases after the U.S. at 34.2 million and has suffered 455,653 deaths. Brazil has second highest death toll at 606,646 and 21.7 million cases. In Europe, Russia has the most fatalities at 229,672 deaths, followed by the U.K. at 140,253.
1:13 a.m. Oct. 22, 2021 - By Ciara Linnane
Coronavirus tally: Global cases of COVID-19 top 242.5 million and CDC approves expanded booster programThe global tally for the coronavirus-borne illness climbed above 242.5 million on Friday, while the death toll edged above 4.93 million, according to . The U.S. continues to lead the world with a total of 45.3 million cases and 733,218 deaths. The U.S. is averaging more than 1,500 deaths a day, although cases and hospitalizations are declining. The Centers for Disease Control and Prevention on Thursday agreed to extend COVID-19 boosters to Americans who got the Moderna or Johnson & Johnson vaccine and said anyone eligible for an extra dose can get a brand different to the one they got as primary dose, The Food and Drug Administration had already authorized such an expansion of the nation's booster campaign on Wednesday, and it was also endorsed Thursday by a CDC advisory panel. CDC Director Dr. Rochelle Walensky had the final word on who gets the extra doses. India is second by cases after the U.S. at 34.1 million and has suffered 453,042 deaths. Brazil has second highest death toll at 604,679 and 21.7 million cases. In Europe, Russia has the most fatalities at 224,369 deaths, followed by the U.K. at 139,562.
1:18 a.m. Oct. 21, 2021 - By Ciara Linnane
Coronavirus tally: Global cases of COVID-19 top 242 million and FDA backs Moderna, J&J boosters and mix-and-matchThe global tally for the coronavirus-borne illness climbed above 242 million on Wednesday, while the death toll edged above 4.92 million, according to . The U.S. continues to lead the world with a total of 45.2 million cases and 731,265 deaths. The U.S. is averaging more than 1,500 deaths a day, although cases and hospitalizations are declining. U.S. regulators on Wednesday signed off on extending COVID-19 boosters to Americans who got the Moderna or Johnson & Johnson vaccine and said anyone eligible for an extra dose can get a brand different from the one they received initially, The agency's decisions mark a big step toward expanding the U.S. booster campaign, which began with extra doses of the Pfizer vaccine last month. But before more people roll up their sleeves, the Centers for Disease Control and Prevention will consult an expert panel Thursday before finalizing official recommendations for who should get boosters and when. India is second by cases after the U.S. at 34.1 million and has suffered 452,811 deaths. Brazil has second highest death toll at 604,228 and 21.7 million cases. In Europe, Russia has the most fatalities at 223,331 deaths, followed by the U.K. at 139,444.
3:48 a.m. Oct. 20, 2021 - By Jaimy Lee
White House: Children will be able to get COVID-19 shots from their pediatriciansThe White House on Wednesday announced a plan detailing how the U.S. plans to roll out COVID-19 vaccines for children between the ages of 5 and 11 years old if and when COVID-19 shots are authorized for this age group. White House officials said there is enough vaccine to immunize all 28 million children in this age group, and kids will be able to get a shot at 25,000 pediatricians' offices, in addition to 100 children's hospitals, "tens of thousands" of pharmacies, and some school and community sites. A Food and Drug Administration advisory committee is scheduled to meet Tuesday to discuss BioNTech SE and Pfizer Inc.'s application for authorization for elementary school-aged children; it will vote on whether the vaccine is safe and effective in this age group, and then the FDA will issue its decision. The Centers for Disease Control and Prevention also has to weigh in.
1:28 a.m. Sept. 30, 2021 - By Ciara Linnane
Coronavirus tally: Global cases of COVID-19 top 233.2 million and CDC urges pregnant or trying to get pregnant to get shotsThe global tally for the coronavirus-borne illness climbed above 233.2 million on Thursday, while the death toll rose above 4.77 million, according to . The U.S. continues to lead the world with a total of 43.3 million cases and 695,116 deaths. The U.S. is still averaging more than 2,000 deaths a day, the most since late February, although new cases and hospitalizations are declining. The Centers for Disease Control and Prevention on Wednesday issued a health advisory urging those who are pregnant, lactating, and trying to get pregnant to get a COVID-19 vaccine. The agency said 31% of people who are pregnant have been vaccinated, a figure that is much lower than the 65% of people in the U.S. who are eligible for a shot and are fully vaccinated. There have been at least 125,000 pregnant individuals with confirmed cases of COVID-19; 22,000 have been hospitalized and 161 people died. Pregnancy can put people at higher risk of severe illness, hospitalization, and death if they contract the virus. India is second by cases after the U.S. at 33.7 million and has suffered 448,062 deaths. Brazil has second highest death toll at 596,122 and 21.4 million cases. In Europe, Russia has most fatalities at 202,700, followed by the U.K. at 136,906.
8:33 a.m. Sept. 29, 2021 - By Jaimy Lee
CDC urges individuals who are pregnant or trying to get pregnant to get a COVID-19 shotThe Centers for Disease Control and Prevention on Thursday issued a urging those who are pregnant, lactating, and trying to get pregnant to get a COVID-19 vaccine. The public-health agency said 31% of people who are pregnant have been vaccinated, a figure that is much lower than the 65% of people in the U.S. who are eligible for a shot and are fully vaccinated. There have been at least 125,000 pregnant individuals with confirmed cases of COVID-19; 22,000 have been hospitalized and 161 people died. Pregnancy can put people at higher risk of severe illness, hospitalization, and death if they contract the virus. They also have a higher risk of preterm birth, according to the CDC.
8:16 a.m. Sept. 24, 2021 - By Jaimy Lee
CDC: We are not changing the definition of 'fully vaccinated' now that COVID-19 boosters are available The Centers for Disease Control and Prevention does not plan to change the definition of what it means to be "fully vaccinated" right now that BioNTech SE and Pfizer Inc.'s COVID-19 booster shots are available for a large group of the U.S. population. During a White House briefing on Friday, CDC director Rochelle Walensky said "we need to have more experience with our third shot and have more people eligible or recommended to receive it, before we change that definition." The Food and Drug Administration on Wednesday authorized a third booster dose of Pfizer's two-dose vaccine, making it the first vaccine to receive regulatory authorization for a booster. Moderna Inc.'s application for a booster shot for its two-dose vaccine is currently under review at the FDA.
1:28 a.m. Sept. 24, 2021 - By Ciara Linnane
Coronavirus tally: Global cases of COVID-19 top 230.6 million, CDC head breaks with agency to recommend boosters for at-risk workers The global tally for the coronavirus-borne illness climbed above 230.6 million on Friday, while the death toll rose to 4.73 million, according to . The U.S. continues to lead the world with a total of 42.7 million cases and 684,357 deaths. The U.S. is averaging more than 2,000 deaths a day, the most since late February. Advisers to the Centers for Disease Control and Prevention ended a meeting Thursday with a vote to offer vaccine boosters to people 65 and older and those aged 50 to 64 who are at risk of severe illness, It offered the option to give younger adults with weak immune systems a booster too, while stressing that getting unvaccinated people to get their first shots remains a priority. Dr. Rochelle Walensky, head of the CDC, overruled the panel by recommending boosters also be given to front line workers, India is second by cases after the U.S. at 33.6 million and has suffered 446,368 deaths. Brazil has second highest death toll at 592,964 and 21.3 million cases. In Europe, Russia has most fatalities at 198,644, followed by the U.K. at 136.156.
2:34 a.m. Sept. 22, 2021 - By Jaimy Lee
CDC committee to meet today and Thursday to again discuss BioNTech and Pfizer's COVID-19 boosterA Centers for Disease Control and Prevention committee is Wednesday and Thursday to again discuss the science and possible administration plan for BioNTech SE and Pfizer Inc.'s COVID-19 booster shot. The CDC's Advisory Committee on Immunization Practices sets out the guidelines for how vaccines should be used in the U.S. The Food and Drug Administration has not approved or authorized an extra dose of the BioNTech and Pfizer vaccine except in people who are immuno-compromised, and an influential FDA committee last week recommended that boosters to older people and those who are at higher risk of severe disease. Some experts have suggested that the FDA decision is coming this week.
1:30 a.m. Sept. 22, 2021 - By Ciara Linnane
Coronavirus tally: Global cases of COVID-19 top 229.5 million and CDC advisers to meet to discuss boostersThe global tally for the coronavirus-borne illness climbed above 229.5 million on Wednesday, while the death toll rose to 4.71 million, according to . The U.S. continues to lead the world with a total of 42.4 million cases and 678,503 deaths. A team of advisers to the Centers for Disease Control and Prevention are scheduled to meet later Wednesday to decide on booster shots of the Pfizer/BioNTech COVID vaccine, The meeting comes after of a committee of advisers to the Food and Drug Administration, who rejected a proposal to offer boosters to everyone above the age of 16, but in favor of offering them to people older than 65 or with weakened immune systems. The CDC must now decide which patient groups might need boosters. The U.S. is now averaging 2,046 deaths a day, , the most since March 1, and are almost entirely unvaccinated people. India is second by cases after the U.S. at 33.5 million and has suffered 445,768 deaths. Brazil has second highest death toll at 591,440 and 21.2 million cases. Brazil's health minister Marcelo Queiroga tested positive for COVID on Tuesday in New York, where he was attending the U.N.'s General Assembly. In Europe, Russia has most fatalities at 196,235, followed by the U.K. at 135,793.
4:29 a.m. Sept. 15, 2021 - By Jaimy Lee
Pfizer cites 'totality' of clinical data in bid for COVID-19 booster approvalShares of Pfizer Inc. gained 0.1% in premarket trading on Wednesday after the drug maker said the "totality" of clinical data indicates that people who are at least 16 years old and were vaccinated with the COVID-19 shot that it developed with BioNTech SE should get a booster after six months. In a published Wednesday morning by the Food and Drug Administration in advance of an advisory committee meeting set for Friday, Pfizer said its Phase 3 substudy examined 306 people between the ages of 18 and 55 years old who got a third dose. It found that an extra dose is considered safe and increased neutralizing antibody titers against the original strain of the virus as well as the beta and delta variants to a higher rate than what was reported after two doses in the clinical trials last year. Younger participants were more likely to report systemic events after the second and third doses than the first dose; fever was more common after the third dose. No adverse events were reported in the first month after the third dose. Pfizer also cited research conducted by Israel, the Centers for Disease Control and Prevention, and the hospital system Kaiser Permanente in the document, saying that data from Israel "suggest reduced effectiveness against severe disease could eventually follow observed reductions in effectiveness against SARS-CoV-2 infections." Pfizer's stock is up 21.4% this year, while the S&P 500 has gained 18.9%.
1:38 a.m. Sept. 13, 2021 - By Ciara Linnane
Coronavirus tally: Global cases of COVID-19 top 224.7 million and Biden to announce new steps ahead of UN meeting The global tally for the coronavirus-borne illness climbed above 224.7 million on Monday, while the death toll rose to 4.63 million, according to . The U.S. continues to lead the world with a total of 40.9 million cases and 659,975 deaths. The daily average of new cases over the past seven days eased to 145.724 as of Sunday, down from a recent peak of 166,105 on Sept. 1 and 7% less than what it was two weeks ago, according to . The daily average for deaths rose to 1,648, up 27% in two weeks and the most since March. The daily average for hospitalizations of 100,382 was down from a peak of 102,621 on Sept. 3 and down 1% from two weeks ago. The number of people that have been fully vaccinated grew to 178.7 million, or 53.8% of the total U.S. population, according to , while the number of people who have received at least one dose of a vaccine rose to 209.4 million, or 63.1% of the total population. U.S. Surgeon General Dr. Vivek Murthy said President Joe Biden will announce new steps to slow the spread of the virus ahead of the U.N. General Assembly session that is scheduled to start on Tuesday, Murthy did not specify what those steps would be. India is second by cases after the U.S. at 33.3 million and has suffered 442,874 deaths. Brazil has second highest death toll at 585,851 and 20.9 million cases. In Europe, Russia has most fatalities at 190,031, followed by the U.K. at 134,525.
1:28 a.m. Sept. 10, 2021 - By Tomi Kilgore
Coronavirus tally: Daily average of new COVID-19 cases dips, but deaths rise to 6-month highThe global tally for the coronavirus-borne illness climbed to 223.23 million as of early Friday, while the death toll rose to 4,606,927, according to . The U.S. continues to lead the world with a total of 40.60 million cases and 654,598 deaths. The daily average of new cases over the past seven days was 147,816 as of Thursday, down from a recent peak of 166,105 on Sept. 1 and 5% less than what it was two weeks ago, according to . The daily average for deaths kept rising to 1,579, up 28% in two weeks and the most since March 9. The daily average for hospitalizations of 100,610 was down from a peak of 102,621 on Sept. 3 but up 1% from two weeks ago. The number of people that have been fully vaccinated grew to 177.43 million, or 53.4% of the total U.S. population, according to , while the number of people who have received at least one dose of a vaccine rose to 208.31 million, or 62.7% of the total population. In a speech from the White House late Thursday, President Joe Biden rolled out a " " to fight COVID-19, including new vaccine mandates, as he warned the country about a "tough stretch" in the fight against the delta variant.
7:30 a.m. Sept. 3, 2021 - By Ciara Linnane
Government health officials tell White House to scale back booster plan: reportGovernment health officials have advised the White House to scale back President Joe Biden's promise to offer boosters to vaccinated Americans beginning later this month, because available data are insufficient to determine they are necessary, citing unnamed people described as familiar with the discussion. Dr. Janet Woodcock, the acting commissioner of the Food and Drug Administration, and Dr. Rochelle P. Walensky, director of the Centers for Disease Control and Prevention, told the White House that they will only be able to determine in the coming weeks whether boosters are necessary for people who received the vaccine developed by Pfizer Inc. and German partner BioNTech SE , and, even then, they may only be needed by certain individuals. Biden said the government would only act with the approval of the FDA. But health experts were concerned that the Biden government was getting ahead of itself and ahead of its own regulatory agencies. The FDA is also awaiting data from Israel, which is already administering boosters to people 12 and older amid concerns that the vaccine's potency wanes over time. The FDA wants to see the underlying data on which that decision was based.
10:46 a.m. Sept. 2, 2021 - By Jaimy Lee
FDA committee to discuss COVID-19 booster shotsAn influential Food and Drug Administration advisory committee plans to meet Sept. 17 to discuss extra doses of the COVID-19 vaccines, including the application filed by BioNTech SE and Pfizer Inc. for a third dose of their COVID-19 shot. Moderna Inc. on Wednesday also submitted its application for a booster dose of its COVID-19 vaccine. The FDA's Vaccines and Related Biological Products Advisory Committee traditionally recommends whether the FDA should authorize or approve a vaccine or drug. The regulator is not required to follow the advice of the committee but it often does. The Biden administration previously said that COVID-19 booster shots will be available to adults starting Sept. 20, though from the FDA and the Centers for Disease Control and Prevention. "The FDA will review the supplemental application as expeditiously as possible, while still doing so in a thorough and science-based manner," Dr. Peter Marks, the director of the FDA's Center for Biologics Research and Evaluation, said in a on Wednesday.
2:04 a.m. Sept. 1, 2021 - By Ciara Linnane
CDC study finds COVID-19 increases risk of myocarditis almost 16 times although it still remains rareA published by the Centers for Disease Control and Prevention late Tuesday found that patients with COVID-19 had nearly 16 times the risk of developing myocarditis than people who did not have it, with risk varying by age and sex. Myocarditis is an inflammation of the heart muscle that is associated with viral infections, and can cause hospitalization, heart failure and sudden death. "These findings underscore the importance of implementing evidence-based COVID-19 prevention strategies, including vaccination, to reduce the public health impact of COVID-19 and its associated complications," the authors wrote. The study was conducted in the period stretching from March of 2020 through January of 2021. By age, risk ratios ranged from about 7.0 for patients aged 16-39 years to greater than 30.0 for patients aged above 16 years or above 75 years. The data were obtained from the Premier Healthcare Database Special COVID-19 Release, a broad hospital-based database. The CDC analysis emphasized that myocarditis is still a rare occurrence.
1:23 a.m. Aug. 30, 2021 - By Ciara Linnane
Coronavirus tally: Global cases of COVID-19 top and WHO fears possible 236,000 new deaths in Europe by Dec. 1The global tally for the coronavirus-borne illness climbed above 216.4 million on Monday, while the death toll rose to 4.5 million, according to . The U.S. leads the world with a total of 38.8 million cases and 637,539 deaths. The daily average of new cases over the past seven days rose to 156,886 as of Sunday, up 20% from two weeks ago, according to . The daily average for deaths increased to 1,296 up 96% in two weeks, trending above 1,000 for the first time since March, the tracker shows. The daily average for hospitalizations rose to 100,319, up 24% from two weeks ago. The number of people that have been fully vaccinated grew to 173.5 million, or 52.3% of the total U.S. population, according to , while the number of people who have received at least one dose of a vaccine edged up to 204.4 million, or 61.6% of the total population. The head of the World Health Organization for Europe said Monday another 236,000 deaths are possible in Europe by Dec. 1, amid flattening vaccination rates and vaccine hesitancy in some of the continent's poorer countries, AFP reported. "Last week, there was an 11 percent increase in the number of deaths in the region -- one reliable projection is expecting 236,000 deaths in Europe, by December 1," WHO Europe director Hans Kluge told reporters at a briefing. India has the second highest death toll after the U.S. at 438,210 and is third by cases at 32.7 million, the JHU data shows. Brazil has second highest death toll at 579,308 and has 20.7 million cases. In Europe, Russia has 179,233 deaths, followed by the U.K. with 132,760.
1:55 a.m. Aug. 27, 2021 - By Ciara Linnane
Coronavirus tally: Global cases of COVID-19 top 214.6 million and U.S. deaths averaging more than 1,000 a day for first time since MarchThe global tally for the coronavirus-borne illness climbed above 214.6 million on Friday, while the death toll rose to 4.47 million, according to . The U.S. leads the world with a total of 38.4 million cases and 633,566 deaths. The daily average of new cases over the past seven days rose to 156,296 as of Thursday, up 24% from two weeks ago, according to . The daily average for deaths increased to 1,233, up 100% in two weeks, and above 1,000 for the first time since March, the tracker shows. The daily average for hospitalizations rose to 96,586, up 29% from two weeks ago. The number of people that have been fully vaccinated grew to 172.2 million, or 51.9% of the total U.S. population, according to , while the number of people who have received at least one dose of a vaccine edged up to 202.9 million, or 61.1% of the total population. A new study published in medical journal The Lancet found that nearly half of COVID-19 patients still have at least one symptom a year after contracting the illness, The study involved 1,286 patients admitted to Jin Yin-tan Hospital in Wuhan, China, who were discharged between Jan. 7 and May 29 of 2020. India has the second highest death toll after the U.S. at 436,861 and is third by cases at 32.6 million, the JHU data shows. Brazil has second highest death toll at 577,565 and has 20.7 million cases. In Europe, Russia has 176,904 deaths, followed by the U.K. with 132,466.
9:37 a.m. Aug. 26, 2021 - By Jaimy Lee
CDC: Overdoses of ivermectin are risingThere has been a "rapid increase" in prescriptions of ivermectin among people looking to treat or prevent COVID-19 cases, according to a issued Thursday by the Centers for Disease Control and Prevention. Ivermectin is an approved treatment for parasitic worms in animals and some rare conditions in humans, but not COVID-19 infections. "Adverse effects associated with ivermectin misuse and overdose are increasing, as shown by a rise in calls to poison control centers reporting overdoses and more people experiencing adverse effects," the CDC said Thursday. The Food and Drug Administration earlier this week , which is not proven to treat COVID-19. "You are not a horse," the regulator said in a tweet that has since gone viral. The drug is one of several therapies that are but have become a worrisome issue for public-health experts as people seek alternative ways to address COVID-19 infections.
1:18 a.m. Aug. 26, 2021 - By Ciara Linnane
Coronavirus tally: Global cases of COVID-19 edges toward 214 million as U.S. likely to approve boosters at 6 months after vaccineThe global tally for the coronavirus-borne illness climbed to 213.9 million Thursday, while the death toll rose to 4.46 million, according to . The U.S. leads the world with a total of 38.2 million cases and 632,272 deaths. The daily average of new cases over the past seven days rose to 152,341 as of Wednesday, up 23% from two weeks ago, according to . The daily average for deaths increased to 1,165, up 111% in two weeks. The daily average for hospitalizations rose to 5,240, up 32% from two weeks ago with more than 90,000 patients currently in hospitals. The number of people that have been fully vaccinated grew to 171.8 million, or 51.7% of the total U.S. population, according to , while the number of people who have received at least one dose of a vaccine edged up to 202.5 million, or 61% of the total population. Federal regulators are likely to approve a COVID-19 booster shot for vaccinated adults starting at least six months after the previous dose rather than the eight-month gap they previously announced, a person familiar with the plans said, as the Biden administration steps up preparations for delivering boosters to the public,
2:14 a.m. Aug. 25, 2021 - By Tomi Kilgore
Coronavirus tally: Daily average of COVID-19 cases rises to 7-month high, as J&J data supports booster shotsThe global tally for the coronavirus-borne illness climbed to 213.30 million as of early Wednesday, while the death toll rose to 4,454,812, according to . The U.S. led the world with a total of 38.08 million cases and 630,838 deaths. The daily average of new cases over the past seven days rose to 151,441 as of Tuesday, up 28% from two weeks ago, and the highest count since Jan. 29, according to . The daily average for deaths increased to 1,116, up 84% in two weeks and the most since March 19. The daily average for hospitalizations of rose to 94,082, up 35% from two weeks ago and the most since Feb. 6. The number of people that have been fully vaccinated grew to 171.4 million, or 51.6% of the total U.S. population, according to , while the number of people who have received at least one dose of a vaccine edged up to 202.04 million, or 60.9% of the total population. Johnson & Johnson announced Wednesday data that supported the use of a COVID-19 vaccine booster shot, eight months after people previously received J&J's single-shot vaccine.
1:22 a.m. Aug. 24, 2021 - By Tomi Kilgore
Coronavirus tally: Daily average for new cases, deaths and hospitalizations keep climbing to multi-month highsThe global tally for the coronavirus-borne illness climbed to above 212.61 million as of early Tuesday, while death toll rose to 4,442,545, according to . The U.S. led the world with a total of 37.94 million cases and 629,411 deaths. The daily average of new cases over the past seven days rose to 150,625 as of Monday, up 29% from two weeks ago, and the highest count since Jan. 30, according to . The daily average for deaths increased to 1,057, up 91 in two weeks and the most since March 24. The daily average for hospitalizations of 93,318 was up 39% from two weeks ago and the most since Feb. 6. The number of people that have been fully vaccinated rose to 171.1 million, or 51.5% of the total U.S. population, according to , while the number of people who have received at least one dose of a vaccine edged up to 201.7 million, or 60.8% of the total population. Hopes that vaccination rates would increase were boosted by the Food and Drug Administration's developed by Pfizer Inc. and BioNTech SE on Monday for people at least 16 years old.
1:51 a.m. Aug. 23, 2021 - By Tomi Kilgore
Coronavirus tally: Average daily U.S. death toll tops 1,000 for first time in 5 months, FDA set to approve Pfizer vaccineThe global tally for the coronavirus-borne illness climbed to 211.9 million as of early Monday, while death toll rose to 4,432,694, according to . The U.S. led the world with a total of 37.71 million cases and 628,503 deaths. The daily average of new cases over the past seven days rose to 149,675 as of Sunday, up 36% from two weeks ago, but down from 150,138 on Saturday, according to . The daily average for deaths increased to 1,008, topping the 1,000 mark for a second-straight day, and up 95% in two weeks, and the most since March 25. Hospitalizations of 92,482 was up 43% from two weeks ago and the most since Feb. 6. The number of people that have been fully vaccinated rose to 170.82 million, or 51.5% of the total U.S. population, according to . The Food and Drug Administration is Pfizer Inc.'s and partner BioNTech SE's COVID-19 vaccine as early as Monday.
1:45 a.m. Aug. 20, 2021 - By Tomi Kilgore
Coronavirus tally: U.S. daily average of COVID-19 cases, deaths and hospitalization rise to multi-month highsThe global tally for the coronavirus-borne illness climbed above 210 million as of early Friday, while death toll rose to 4,404,511, according to . The U.S. led the world with a total of 37.29 million cases and 625,166 deaths. The daily average of new cases over the past seven days rose to 143,827 as of Thursday, up 44% from two weeks ago and the most since Feb. 1, according to . The daily average for deaths increased to 911, up 108% in two weeks, and the most since March 31, while hospitalizations of 86,877 was up 53% from two weeks ago and the most since Feb. 9. The number of people that have been fully vaccinated rose to 169.59 million, or 51.1% of the total U.S. population, according to . AstraZeneca PLC said Friday that in a late stage trial. "There were no cases of severe Covid-19 or Covid-19-related deaths in those treated with AZD7442," the company said.
1:36 a.m. Aug. 19, 2021 - By Tomi Kilgore
Coronavirus tally: Global cases of COVID-19 tops 209 million, U.S. daily average of deaths rises to 4-month highThe global tally for the coronavirus-borne illness climbed above 209.3 million as of early Thursday, while death toll rose to 4,393,138, according to . The U.S. led the world with a total of 37.16 million cases and 624,253 deaths. The daily average of new cases over the past seven days ticked back above 140,000 on Wednesday, after a brief one-day dip below it on Tuesday, according to . At 140,893, the daily average is up 47% from two weeks ago, and up from 32,305 from a month ago. The daily average for deaths rose to 809, up 97% from two weeks ago and the highest seen since early April, while the daily average of hospitalizations of 85,118 is up 56% from two weeks ago and the highest since early February. The number of people that have been fully vaccinated rose to 169.19 million, or 51.0% of the total U.S. population, according to . Federal health officials said Wednesday that those who have received the vaccines from Moderna Inc. and from Pfizer Inc. and BioNTech SE will be , starting in September.
1:55 a.m. Aug. 18, 2021 - By Tomi Kilgore
Coronavirus tally: Daily average of new cases slips, to snap a 39-day streak of increases based on NYT dataThe global tally for the coronavirus-borne illness climbed above 208.6 million as of early Wednesday, while death toll rose to 4,383,333, according to . The U.S. remained the world leader with 37.02 million cases and 623,322 deaths. On a daily basis, the seven-day average for cases slipped to 139,872 on Tuesday from 142,414 on Monday, to snap a 39-day streak of increases. The daily average was still up 52% from two weeks ago, and 4.5 times the average of 31,138 a month ago, . The daily average of deaths slipped to 696 on Tuesday from 704 on Monday, while hospitalizations increased to 83,291 from 82,519 on Monday, the most since Feb. 11. The number of people that have been fully vaccinated rose to 168.90 million, or 50.9% of the total U.S. population, according to . The U.S. is expected to announce Wednesday that most vaccinated Americans eight months after being fully vaccinated.
1:27 a.m. Aug. 17, 2021 - By Tomi Kilgore
Coronavirus tally: Global cases of COVID-19 nears 208 million, as U.S. reportedly set to recommend boostersThe global tally for the coronavirus-borne illness climbed above 207.9 million as of early Tuesday, while death toll rose to 4,372,554, according to . In the U.S., cases reached 36.89 million while deaths increased to 622,322, with both leading the world. On a daily basis, the seven-day average for cases grew to 141,365 on Monday, more than four times the daily average of 30,901 a month ago, and the most since Feb. 2, according to . The seven-day average for deaths rose to 704, up from 273 a month ago and the most since May 4, while hospitalizations rose to 81,556, up from 23,432 a month ago and the most since Feb. 12. The number of people that have been fully vaccinated rose to 168.69 million, or 50.8% of the total U.S. population, according to . The U.S. is set to announce that most vaccinated Americans shot eight months after being fully vaccinated, according to late Monday.
2:36 a.m. Aug. 16, 2021 - By Tomi Kilgore
Coronavirus tally: Global cases of COVID-19 top 207 million, as U.S.'s daily average rises to 6-month highThe global tally for the coronavirus-borne illness climbed above 207.2 million on Monday, while death toll rose to 4,364,409, according to . The U.S. continued to lead the world in cases with 36.68 million and in deaths with 621,635. On a daily basis, the seven-day average for new COVID-19 cases rose to 130,808 as of Sunday, , up 64% from two weeks ago, to mark the 11-straight day above 100,000 and the highest rate since Feb. 3. The 7-day average of deaths was 662 on Sunday, up 113% from two weeks ago and the highest since early May, while the number hospitalized has increased 65% to 76,088. The number of people fully vaccinated in the U.S. was 168.36 million, or 50.7% of the total population as of Sunday, according to , including 61.7% of the adult population. The number of adults receiving at least one dose grew to 185.88 million, or 72%. "We've got to get people vaccinated," said Dr. Anthony Fauci, chief medical adviser to President Biden, on CBS's "Face the Nation" on Sunday. "We have about 90 million people who are eligible to be vaccinated, who are not vaccinated. And that's very highly concentrated in the southern states, including Mississippi and other states in which you have, compared to the general average of vaccinations in the country, an under vaccinated group."
4:00 a.m. Aug. 13, 2021 - By MarketWatch
The S&P 500 is nearly 99% above its March 2020 low. These 3 big-tech charts will tell you if things are about to unravelOur call of the day says big technology will be the canary in the coalmine telling us whether the S&P 500 is due to correct.
12:00 p.m. Aug. 12, 2021 - By MarketWatch
Disney produces best earnings and sales since before pandemic, stock pops 5% higherThe Walt Disney Co. reported its strongest sales and profit since before the COVID-19 pandemic began on Thursday, sending shares 5% higher in late trading.
2:23 a.m. Aug. 12, 2021 - By Jaimy Lee
CDC advisory committee to meet Friday, discuss COVID-19 booster shotsAn influential group of advisors to the Centers for Disease Control and Prevention is scheduled to meet Friday to discuss whether people who are immunocompromised should receive COVID-19 booster shots. This is the main item on the agenda for the CDC's Advisory Committee on Immunization Practices , which will be webcast. Media outlets, citing anonymous sources, that the Food and Drug Administration is expected to update the emergency-use authorizations for Pfizer Inc. and Moderna Inc.'s COVID-19 shots to allow them to be used as booster shots in people with weaker immune systems.
4:36 a.m. Aug. 3, 2021 - By Mark Decambre
Dow industrials gain modestly early Tuesday but COVID delta-variant worries keep stock market in check U.S. stock indexes Tuesday rose modestly higher as traders grappled with concerns over how the global economy will withstand COVID-19's delta variant as well as Chinese regulatory actions. The Dow Jones Industrial Average rose 0.3% at 34,924, the S&P 500 index advanced 0.2% at 4,395, while the Nasdaq Composite Index climbed 0.1% to reach 14,702. The market has been buoyed by strong corporate quarterly results but investors are still watching to see if the U.S. central bank will continue to support the economy, helping to spurt further expansion for equities. The Centers for Disease Control and Prevention said Monday the delta variant is "highly contagious" and urged unvaccinated people to get their shots and for employers to require vaccination. "To put this in perspective: if you get sick with the alpha variant, you could infect about two other unvaccinated people," said CDC Director Dr. Rochelle Walensky. "If you get sick with the delta variant, we estimate that you can infect about five other unvaccinated people - more than twice as many as the original strain," she explained.
1:56 a.m. Aug. 3, 2021 - By Ciara Linnane
Coronavirus tally: Global cases of COVID-19 near 199 million , CDC urges vaccination against 'highly contagious' delta variantThe global tally for the coronavirus-borne illness headed above 198.9 million on Tuesday, while the death toll climbed above 4.23 million according to . The U.S. leads the world with a total of 35.1 million cases and in deaths with 613,679 as the highly infectious delta variant continues to spread fast, especially in states with low vaccination rates. The Centers for Disease Control and Prevention said Monday the delta variant and urged unvaccinated people to get their shots and for employers to require vaccination. "The delta variant is highly contagious," CDC director Dr. Rochelle Walensky said during the briefing. "To put this in perspective: if you get sick with the alpha variant, you could infect about two other unvaccinated people. If you get sick with the delta variant, we estimate that you can infect about five other unvaccinated people - more than twice as many as the original strain." India is second by cases at 31.7 million and third by deaths at 425,195 according to its official numbers, which are expected to be undercounted. Brazil is second in deaths at 557,223, but is third in cases at 19.9 million. Mexico has fourth-highest death toll at 241,279 but has recorded just 2.9 million cases, according to its official numbers. In Europe, Russia continues to pull ahead of the U.K. by deaths at 158,263, while the U.K. has 130,039, making Russia the country with the fifth-highest death toll in the world and highest in Europe.
11:36 a.m. Aug. 2, 2021 - By Jaimy Lee
White House: 1 out of 3 cases of COVID-19 are in Florida and TexasOne out of three COVID-19 cases occurred in Florida and Texas over the past week, and 17% of cases came from seven states with the lowest vaccination rates in the U.S., the White House said Monday. "We remain concerned about the continued rise in cases, driven by the delta variant," Jeff Zients, White House COVID-19 response coordinator, told reporters during a news briefing. "These cases are concentrated in communities with lower vaccination rates." That said, the overall vaccination rate is increasing; more than 3 million Americans have received a first shot of a COVID-19 vaccine in the past seven days. At least of people in the U.S. have been fully vaccinated, as of Monday, according to the Centers for Disease Control and Prevention.
10:11 a.m. Aug. 2, 2021 - By Robert Schroeder
Biden asked CDC for 30-day eviction ban, White House says President Joe Biden on Sunday "raised the prospect" of a new, 30-day eviction moratorium focused on U.S. counties with high or substantial COVID-19 case rates, the White House said Monday. An eviction ban expired at midnight Saturday. The White House said that to date, Centers for Disease Control and Prevention Director Rochelle Walensky and her team haven't been able to find legal authority for a new, targeted eviction moratorium. Biden is now asking his policy and other teams to reexamine whether there are other authorities to take more actions to stop evictions, the White House said. The president is also calling on states to extend or put in place eviction moratoriums for at least the next two months.
Browse topics:

Filter results by

Location

Us (220)

Europe (36)

Asia Pacific (35)

Eu (27)

China (16)

Latin America (14)

Link to MarketWatch's Slice.